Director/PDMR Shareholding

RNS Number : 1431C
East Imperial PLC
18 February 2022
 

18 February 2022

East Imperial plc

 

("East Imperial" or the "the Company")

   

Director/PDMR Shareholding

 

East Imperial, the global purveyor of ultra-premium beverages , announces that today the Company received notice that Dr. Olufunke Abimbola purchased 50,000 ordinary shares of 1 pence each ("Ordinary Shares") at a price of 9.45 pence per share on 17 February 2022.

 

- Ends -

 

Enquiries:  

MHP Communications

Peter Hewer  +44 (0) 770 9326 261

Rachel Mann  +44 (0) 758 5301 464

eastimperial@mhpc.com  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Dr. Olufunke Abimbola

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

East Imperial plc

b)

 

LEI

 

213800OI98RNUFC3IG61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of nominal value 1 pence each

 

 

GB00BMZ1ND56

b)

 

Nature of the transaction

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

9.45p

 

50,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Total

 

 

50,000

 

9.45p

 

£4,725.00

e)

 

Date of the transaction

 

17 February 2022

f)

 

Place of the transaction

 

London Stock Exchange, Main Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFISUAEESELE
UK 100

Latest directors dealings